{"log_id": 1728220038263552347, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.005155, "average": 0.964627, "min": 0.70375}, "location": {"width": 914, "top": 165, "height": 32, "left": 158}, "words": "口服避孕药,利福平,苯巴比妥和卡马西平,噻嗪类药物,皮质激素,达那唑,甲状腺激素,奥曲肽"}, {"probability": {"variance": 0.013224, "average": 0.95132, "min": 0.669663}, "location": {"width": 143, "top": 215, "height": 24, "left": 115}, "words": "和拟交感神经药"}, {"probability": {"variance": 0.000738, "average": 0.989395, "min": 0.831409}, "location": {"width": 918, "top": 260, "height": 29, "left": 152}, "words": "β受体阻滞剂会掩盖低血糖症状。当接受瑞格列奈治疗的患者使用或停止使用这些药物时,应密切监测"}, {"probability": {"variance": 0.000402, "average": 0.985739, "min": 0.948169}, "location": {"width": 142, "top": 309, "height": 23, "left": 115}, "words": "者血糖的变化"}, {"probability": {"variance": 0.000287, "average": 0.986166, "min": 0.958085}, "location": {"width": 113, "top": 354, "height": 26, "left": 118}, "words": "【药物过量】"}, {"probability": {"variance": 0.007826, "average": 0.968462, "min": 0.529248}, "location": {"width": 894, "top": 402, "height": 27, "left": 174}, "words": "项在2型糖尿病患者中开展的临床试验中,每周增加瑞格列奈的服药量,在超过6周的时间范围内"}, {"probability": {"variance": 0.007671, "average": 0.963113, "min": 0.467767}, "location": {"width": 954, "top": 448, "height": 27, "left": 111}, "words": "服药量从4mg增加至20mg。患者每日4次在进餐时服药。除与血糖降低相关的可预期的影响外,基本禾出"}, {"probability": {"variance": 0.009918, "average": 0.96826, "min": 0.534932}, "location": {"width": 959, "top": 492, "height": 31, "left": 110}, "words": "现不良事件。由于该研究申通过增加热量摄取的方法以减少低血糖症状的发生、因此药物相对过量会可能"}, {"probability": {"variance": 0.008358, "average": 0.980339, "min": 0.380508}, "location": {"width": 957, "top": 540, "height": 28, "left": 111}, "words": "表现为降糖作用的增大及出现低血糖症状(头晕、出汗、震颤、头痛等)一出现这些反应,应采取有效"}, {"probability": {"variance": 0.012827, "average": 0.965557, "min": 0.362677}, "location": {"width": 957, "top": 585, "height": 32, "left": 108}, "words": "措施纠低血糖(口服碳水化合物)。更严重的低血糖伴有癫痫、意识丧失和昏迷,这种情况下,应静脉输"}, {"probability": {"variance": 0.000294, "average": 0.989389, "min": 0.959683}, "location": {"width": 83, "top": 634, "height": 24, "left": 109}, "words": "入葡萄糖"}, {"probability": {"variance": 0.002885, "average": 0.962738, "min": 0.846395}, "location": {"width": 111, "top": 680, "height": 26, "left": 113}, "words": "【药理毒理】"}, {"probability": {"variance": 0.006329, "average": 0.966419, "min": 0.651904}, "location": {"width": 917, "top": 726, "height": 32, "left": 151}, "words": "本品为短效口服降血糖药,通过促进胰腺β细胞的胰岛素分泌,降低血糖水平。其作用机理是通过与β"}, {"probability": {"variance": 0.000237, "average": 0.991513, "min": 0.929703}, "location": {"width": 962, "top": 772, "height": 32, "left": 104}, "words": "细胞膜上的特定位点结合,关闭细胞膜上ATP依赖性钾通道,使β细胞去极化,导致其钙通道开放,钙的"}, {"probability": {"variance": 0.031217, "average": 0.895494, "min": 0.429578}, "location": {"width": 286, "top": 822, "height": 24, "left": 112}, "words": "内流增,从而促使胰岛素分泌"}, {"probability": {"variance": 0.000392, "average": 0.989297, "min": 0.945158}, "location": {"width": 133, "top": 868, "height": 25, "left": 111}, "words": "【药代动力学"}, {"probability": {"variance": 0.010164, "average": 0.953758, "min": 0.609261}, "location": {"width": 920, "top": 914, "height": 33, "left": 144}, "words": "瑞格列奈经胃肠道快速吸收、导致血浆药物浓度迅速升高。服药后1小时内血浆药物浓度达峰值。然"}, {"probability": {"variance": 0.0055, "average": 0.972379, "min": 0.622808}, "location": {"width": 948, "top": 962, "height": 30, "left": 105}, "words": "后血浆浓度迅速下降,4~6小时内被清除。血浆半衰期约为1小时。瑞格列奈与人血浆蛋白的结合大于98%"}, {"probability": {"variance": 0.009584, "average": 0.965894, "min": 0.429295}, "location": {"width": 957, "top": 1010, "height": 28, "left": 104}, "words": "格列奈儿乎全部被代谢,代谢物未见有任何临床意义的降血糖作用。瑞格列奈及其代谢产物主要白胆汁"}, {"probability": {"variance": 0.005297, "average": 0.974665, "min": 0.582712}, "location": {"width": 691, "top": 1056, "height": 27, "left": 102}, "words": "排泄,很小部分(小于8%)代谢产物自尿排出。粪便中的原形药物少于2%"}, {"probability": {"variance": 0.007783, "average": 0.96681, "min": 0.428426}, "location": {"width": 909, "top": 1103, "height": 28, "left": 143}, "words": "据国外文献报道,对肾功能正常(CrC>80mL/min)、伴有轻微和中度肾功能损伤(CrCl=40~80mL/min"}, {"probability": {"variance": 0.005612, "average": 0.977086, "min": 0.49201}, "location": {"width": 948, "top": 1152, "height": 27, "left": 102}, "words": "和严重肾功能损伤(CrCl=20~40mL/min)的2型糖尿病患者给予单剂瑞格列奈后的稳态药动学做了比较"}, {"probability": {"variance": 0.001469, "average": 0.989141, "min": 0.788153}, "location": {"width": 614, "top": 1199, "height": 26, "left": 102}, "words": "肾功能正常的患者与伴有轻微和中度肾功能损伤的患者间的AUC"}, {"probability": {"variance": 0.00023, "average": 0.988746, "min": 0.947464}, "location": {"width": 294, "top": 1201, "height": 26, "left": 761}, "words": "相似(平均值分别为56.7g/mLh"}, {"probability": {"variance": 0.016669, "average": 0.921865, "min": 0.472887}, "location": {"width": 769, "top": 1247, "height": 27, "left": 102}, "words": "和57.2ng/mL*hr:37.5ng/mL和137.7ng/mL),伴有严重肾功能损优的患者的AUC和C"}, {"probability": {"variance": 0.001467, "average": 0.967122, "min": 0.892415}, "location": {"width": 193, "top": 1247, "height": 48, "left": 871}, "words": "大幅增加(分别"}, {"probability": {"variance": 0.020261, "average": 0.927276, "min": 0.368492}, "location": {"width": 958, "top": 1290, "height": 32, "left": 101}, "words": "为98.0gmLhr和50.7ng/mL),但是这项研究仅仅表明瑞格列杀浓度与西清除率CC)之间存在微弱"}, {"probability": {"variance": 0.002027, "average": 0.986565, "min": 0.752975}, "location": {"width": 959, "top": 1341, "height": 27, "left": 101}, "words": "的关联。伴有轻微和中度肾功能损伤的患者无需调整起始剂量。然而,伴有严重肾功能损伤的2型糖尿病"}, {"probability": {"variance": 0.002023, "average": 0.988176, "min": 0.72451}, "location": {"width": 723, "top": 1388, "height": 27, "left": 98}, "words": "患者的起始剂量应定为0.5mg,然后再谨慎地调整剂量。在肌酐清除率低于20"}, {"probability": {"variance": 2e-06, "average": 0.999094, "min": 0.99534}, "location": {"width": 165, "top": 1390, "height": 24, "left": 893}, "words": "以及需要血液透析"}, {"probability": {"variance": 4.8e-05, "average": 0.996404, "min": 0.978295}, "location": {"width": 290, "top": 1437, "height": 25, "left": 99}, "words": "的肾衰患者中的研究尚未开展过"}, {"probability": {"variance": 0.010555, "average": 0.953432, "min": 0.510983}, "location": {"width": 919, "top": 1485, "height": 27, "left": 139}, "words": "据国外文献报道,在12名健康受试者和12名按照 Child-Pugh分级和咖啡因清除率分级的慢性肝病患"}, {"probability": {"variance": 0.001575, "average": 0.986692, "min": 0.763522}, "location": {"width": 957, "top": 1532, "height": 27, "left": 100}, "words": "者中展开了一项单剂量、标签公开的研究。与健康受试者相比,伴有中度至重度肝功能损伤的患者的瑞格"}], "language": 3}